Compare Bristol-Myers Squibb Co (BMY) vs GoPro Inc (GPRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs GoPro Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B), while GoPro Inc trades at $0.63 (market cap $114.41M). The key difference: Bristol-Myers Squibb Co is far larger — about 1135.7× GoPro Inc's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while GoPro Inc pays none. Which is the better fit depends on your goals.
| BMY | GPRO | |
|---|---|---|
Market Cap | $129.94B | $114.41M |
Sector | Health | Technology |
52-Week High | $65.89 | $2.88 |
52-Week Low | $42.60 | $0.62 |
Enterprise Value | $163.92B | $173.19M |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →
